(Reuters) - Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and ...

Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre ...

Haleon PLC closed 5.73% below its 52-week high of £4.01, which the company reached on September 18th.

The UK-based consumer healthcare company will be modernizing its facility along Brook Road, where it conducts R&D for such ...

Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-12-2024, the company has a total of 16.94 Crore shares outstanding.GSK Pharma Share Price Today is Rs. 2062.30. On previous day, the ...

The sale represents nearly 7.7% of Haleon's issued share capital. Haleon was formed in 2019 through a merger of the consumer healthcare businesses of GlaxoSmithKline (GSK) and Pfizer. Haleon was ...

Deal priced at a 2.8% discount to the prior closing level Shares of Haleon rose on Wednesday after the stake deal Pfizer Inc. sold about 700 million shares in Haleon Plc, further paring its stake in ...

In this note, while we briefly touch upon Pfizer’s performance in 2024, we focus on the impact on PFE stock and how 2025 ...

The sale represents nearly 7.7% of the issued share capital of Haleon, which was created by the merger of GSK and Pfizer's consumer healthcare businesses in 2019. It was spun off from the British ...

The sale of 700 million Haleon shares at 357 pence apiece is a discount of about 2.8% to the stock's closing price on Tuesday ...

GSK has also been selling down its holding, and offloaded its remaining 4.2% stake in May last year Shares in Haleon ticked up 1% as trading got underway on Wednesday, to 370.2p.

Pfizer is a New York-based pharmaceutical and biotechnology firm. Haleon was formed in 2019 as a joint venture of Pfizer and GSK PLC's consumer health businesses. It was listed on the London Main ...